Cybrdi Inc (CYDI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
401 ROSEMONT AVENUE FREDERICK, MD 21701 |
| State of Incorp. | CA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2014 MRQ | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 204 | 956 | |||
| Cash and cash equivalents | 204 | 956 | |||
| Receivables | 6 | 0 | |||
| Inventory, net of allowances, customer advances and progress billings | 849 | 816 | |||
| Inventory | 849 | 816 | |||
| Advances on inventory purchases | 5 | 3 | |||
| Prepaid expense and other current assets | ✕ | ✕ | 93 | ||
| Other undisclosed current assets | 906 | ||||
| Total current assets: | 1,970 | 1,869 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | 1,145 | 1,190 | |||
| Intangible assets, net (including goodwill) | 628 | 661 | |||
| Intangible assets, net (excluding goodwill) | 628 | 661 | |||
| Other undisclosed noncurrent assets | 6,610 | 6,832 | |||
| Total noncurrent assets: | 8,383 | 8,683 | |||
| TOTAL ASSETS: | 10,353 | 10,552 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 822 | 690 | |||
| Accounts payable | 12 | 4 | |||
| Accrued liabilities | 810 | 686 | |||
| Debt | 1,309 | 1,664 | |||
| Other liabilities | 592 | 571 | |||
| Deferred revenue and credits | 126 | 122 | |||
| Deferred tax liabilities | 11 | 10 | |||
| Due to related parties | 2,963 | 2,071 | |||
| Other undisclosed current liabilities | 165 | 149 | |||
| Total current liabilities: | 5,988 | 5,279 | |||
| Noncurrent Liabilities | |||||
| Other undisclosed noncurrent liabilities | 376 | 846 | |||
| Total noncurrent liabilities: | 376 | 846 | |||
| Total liabilities: | 6,364 | 6,125 | |||
| Equity | |||||
| Equity, attributable to parent, including: | 2,954 | 3,375 | |||
| Common stock | 4,314 | 4,314 | |||
| Additional paid in capital | 172 | 172 | |||
| Accumulated other comprehensive income | 1,657 | 1,530 | |||
| Accumulated deficit | (3,526) | (2,977) | |||
| Other undisclosed equity, attributable to parent | 337 | 337 | |||
| Equity, attributable to noncontrolling interest | 1,035 | 1,052 | |||
| Total equity: | 3,988 | 4,427 | |||
| TOTAL LIABILITIES AND EQUITY: | 10,353 | 10,552 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Revenues | 574 | 783 | ||
| Revenue, net | 269 | |||
| Cost of revenue | (390) | (616) | ||
| Cost of goods and services sold | (221) | |||
| Gross profit: | 184 | 167 | ||
| Operating expenses | (726) | (599) | ||
| Operating loss: | (542) | (432) | ||
| Nonoperating expense | (72) | (223) | ||
| Investment income, nonoperating | (221) | (195) | ||
| Other nonoperating income (expense) | 149 | (28) | ||
| Loss from continuing operations before income taxes: | (615) | (655) | ||
| Income tax expense | (2) | (1) | ||
| Loss from continuing operations: | (617) | (656) | ||
| Loss before gain (loss) on sale of properties: | (617) | (656) | ||
| Net loss: | (617) | (656) | ||
| Net income attributable to noncontrolling interest | 68 | 126 | ||
| Net loss available to common stockholders, diluted: | (548) | (530) | ||
Comprehensive Income ($ in thousands)
| 9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Net loss: | (617) | (656) | ||
| Comprehensive loss: | (617) | (656) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (68) | (126) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 264 | 241 | ||
| Comprehensive loss, net of tax, attributable to parent: | (422) | (540) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.